Morgan Stanley’s ADARx Pharmaceuticals ADRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$450K Buy
+22,544
New +$451K ﹤0.01% 5655

Other funds holding ADRX

Morgan Stanley's ADRX Position: Q3 2026 in Review

Morgan Stanley opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 22,544 shares worth $450K. The stake represents ﹤0.01% of the portfolio and ranks #5655 among its holdings.

62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.

  • Morgan Stanley held 22,544 shares of ADARx Pharmaceuticals worth $450K as of Q3 2026.
  • ADARx Pharmaceuticals was a new Morgan Stanley position in Q3 2026.
  • ADARx Pharmaceuticals made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #5655 holding.
  • 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.

Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.